<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id>
      <journal-id journal-id-type="iso-abbrev">Emerging Infect. Dis</journal-id>
      <journal-id journal-id-type="publisher-id">EID</journal-id>
      <journal-title-group>
        <journal-title>Emerging Infectious Diseases</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1080-6040</issn>
      <issn pub-type="epub">1080-6059</issn>
      <publisher>
        <publisher-name>Centers for Disease Control and Prevention</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">21529424</article-id>
      <article-id pub-id-type="pmc">3321774</article-id>
      <article-id pub-id-type="publisher-id">10-1424</article-id>
      <article-id pub-id-type="doi">10.3201/eid1705.101424</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letters to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Quinine-Resistant Malaria in Traveler Returning from French Guiana, 2010</article-title>
        <alt-title alt-title-type="running-head">Running head: Quinine-Resistant Malaria, French Guiana</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Bertaux</surname>
            <given-names>Lionel</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kraemer</surname>
            <given-names>Philippe</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Taudon</surname>
            <given-names>Nicolas</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Trignol</surname>
            <given-names>Aur&#xE9;lie</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Martelloni</surname>
            <given-names>Maryse</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Saidi</surname>
            <given-names>Redouan</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Parzy</surname>
            <given-names>Daniel</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Pradines</surname>
            <given-names>Bruno</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Simon</surname>
            <given-names>Fabrice</given-names>
          </name>
        </contrib>
        <aff id="aff1">Author affiliations: Institut de Recherche Biom&#xE9;dicale des Arm&#xE9;es, Marseille, France (L. Bertaux, N. Taudon, M. Martelloni, D. Parzy, B. Pradines);</aff>
        <aff id="aff2">Laveran Military Teaching Hospital, Marseille (P. Kraemer, A. Trignol, R. Saidi, F. Simon)</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Address for correspondence: Bruno Pradines, Institut de Recherche Biom&#xE9;dicale des Arm&#xE9;es, All&#xE9;e du M&#xE9;decin-Colonel Jamot, Parc du Pharo, BP 60109, 13262 Marseille CEDEX 07, France; email: <email xlink:href="bruno.pradines@free.fr">bruno.pradines@free.fr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>5</month>
        <year>2011</year>
      </pub-date>
      <volume>17</volume>
      <issue>5</issue>
      <fpage>943</fpage>
      <lpage>945</lpage>
      <kwd-group kwd-group-type="author">
        <title>Keywords: </title>
        <kwd>parasites</kwd>
        <kwd>malaria</kwd>
        <kwd>quinine resistance</kwd>
        <kwd>plasmodium falciparum</kwd>
        <kwd>antimalarial drug resistance</kwd>
        <kwd>French Guiana</kwd>
        <kwd>antimicrobial resistance</kwd>
        <kwd>letter</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p><bold>To the Editor:</bold> Resistance of <italic>Plasmodium falciparum</italic> to antimalarial drugs is one of the most worrying problems in tropical medicine. For <italic>P. falciparum</italic> malaria acquired in French Guiana, the combination of quinine and doxycycline is one of the first-line recommended treatments (<xref rid="R1" ref-type="bibr"><italic>1</italic></xref>). Since 1996, only 2 treatment failures with quinine have been reported from that country (<xref rid="R2" ref-type="bibr"><italic>2</italic></xref>). An elevated 50% inhibitory concentration (IC<sub>50</sub>), classified as in vitro quinine resistance, was reported for 17% of 32 <italic>P. falciparum</italic> isolates obtained during 1983&#x2013;1987 in French Guiana (<xref rid="R3" ref-type="bibr"><italic>3</italic></xref>). Throughout 1994&#x2013;2005, isolates were susceptible to quinine, with a mean IC<sub>50</sub> &lt;200 nmol/L (<xref rid="R4" ref-type="bibr"><italic>4</italic></xref>).</p>
    <p>We report quinine treatment failure in a 35-year-old man who was infected during a 3-month stay in Sa&#xFC;l, a rural area of French Guiana. The patient did not use antivectorial or antimalarial prophylaxis. The patient sought treatment with fever 4 days after returning to France on June 22, 2010 (day 0), and a diagnosis of <italic>P. falciparum</italic> malaria was made on the basis of results of a rapid diagnostic test performed by a private medical laboratory. The man, who weighed 58 kg, was treated as an outpatient with 500 mg of quinine to be taken orally 3&#xD7;/d for 7 days; he did not receive doxycycline. He was admitted to the Laveran Military Teaching Hospital in Marseille on July 15 (day 24 and first day of recrudescence) for uncomplicated malaria with a <italic>P. falciparum</italic> parasitemia level of 4%. He was given artemether, 80 mg/d, by intramuscular injection for 3 days. Blood samples taken on day 27 (third day of recrudescence) and day 52 (4 weeks of recrudescence) were negative for <italic>P. falciparum</italic>.</p>
    <p>In vitro testing of drug susceptibility was performed by the standard 42-hour <sup>3</sup>H-hypoxanthine uptake inhibition method (<xref rid="R5" ref-type="bibr"><italic>5</italic></xref>). We assessed susceptibility to 11 antimalarial drugs on the fresh isolate and after culture adaptation (<xref ref-type="table" rid="T1">Table</xref>). The laboratory-adapted strain 3D7, tested 3&#xD7; on the same batch of plates, was used as reference. The strain isolated from the blood sample on day 24 (first day of the recrudescence) showed reduced susceptibility to quinine (1,019 nmol/L), chloroquine (427 nmol/L), and monodesethylamodiaquine (157 nmol/L). The isolate was susceptible to all other antimalarial drugs tested. We assessed gene polymorphisms of <italic>pfcrt</italic> (<italic>P. falciparum</italic> chloroquine resistance transporter), <italic>pfmdr1</italic> (<italic>P. falciparum</italic> multidrug resistance 1 protein), and <italic>pfnhe-1</italic> (<italic>P. falciparum</italic> Na<sup>+</sup>/H<sup>+</sup> exporter 1); the copy number of <italic>pfmdr1</italic> involved in quinoline resistance; and gene polymorphisms of <italic>dhfr</italic> (dihydrofolate reductase, involved in proguanil or pyrimethamine resistance), <italic>dhps</italic> (dihydropteroate synthetase, involved in sulfadoxine resistance), and <italic>cytB</italic> (cytochrome B, involved in atovaquone resistance) (<xref rid="R6" ref-type="bibr"><italic>6</italic></xref>).</p>
    <table-wrap id="T1" position="float">
      <label>Table</label>
      <caption>
        <title>In vitro susceptibility to standard antimalarial drugs of a fresh isolate of <italic>Plasmodium falciparum</italic> and after culture adaptation in comparison with <italic>P. falciparum</italic> 3D7 clone tested with the same plate batches*</title>
      </caption>
      <table frame="hsides" rules="groups">
        <col width="110" span="1"/>
        <col width="76" span="1"/>
        <col width="90" span="1"/>
        <col width="81" span="1"/>
        <col width="54" span="1"/>
        <col width="70" span="1"/>
        <thead>
          <tr>
            <th valign="bottom" align="left" scope="col" rowspan="1" colspan="1">Antimalarial drug</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Fresh isolate IC<sub>50</sub>, nmol/L</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Cultured isolate IC<sub>50</sub>, nmol/L, mean &#xB1; SD&#x2020;</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">3D7 clone IC<sub>50</sub>, nmol/L, mean &#xB1; SD</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">IC<sub>50</sub>, isolate:3D7</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Resistance cutoff value, nmol/L</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Quinine</td>
            <td valign="top" align="center" rowspan="1" colspan="1">1,019</td>
            <td valign="top" align="center" rowspan="1" colspan="1">1,087 &#xB1; 145</td>
            <td valign="top" align="center" rowspan="1" colspan="1">171 &#xB1; 26</td>
            <td valign="top" align="center" rowspan="1" colspan="1">6.0:6.4</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;800</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Chloroquine</td>
            <td valign="top" align="center" rowspan="1" colspan="1">427</td>
            <td valign="top" align="center" rowspan="1" colspan="1">492 &#xB1; 39</td>
            <td valign="top" align="center" rowspan="1" colspan="1">13.9 &#xB1; 2.2</td>
            <td valign="top" align="center" rowspan="1" colspan="1">30.7:35.4</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;100</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Monodesethylamodiaquine</td>
            <td valign="top" align="center" rowspan="1" colspan="1">157</td>
            <td valign="top" align="center" rowspan="1" colspan="1">157 &#xB1; 27</td>
            <td valign="top" align="center" rowspan="1" colspan="1">16.3 &#xB1; 3.5</td>
            <td valign="top" align="center" rowspan="1" colspan="1">9.6:9.6</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;80</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Mefloquine</td>
            <td valign="top" align="center" rowspan="1" colspan="1">16.4</td>
            <td valign="top" align="center" rowspan="1" colspan="1">14.9 &#xB1; 2.2</td>
            <td valign="top" align="center" rowspan="1" colspan="1">53.4 &#xB1; 5.2</td>
            <td valign="top" align="center" rowspan="1" colspan="1">0.31:0.28</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;30</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Lumefantrine</td>
            <td valign="top" align="center" rowspan="1" colspan="1">8.9</td>
            <td valign="top" align="center" rowspan="1" colspan="1">9.0 &#xB1; 3.0</td>
            <td valign="top" align="center" rowspan="1" colspan="1">46.0 &#xB1; 6.0</td>
            <td valign="top" align="center" rowspan="1" colspan="1">0.19:0.20</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;150</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Pyronaridine</td>
            <td valign="top" align="center" rowspan="1" colspan="1">45.2</td>
            <td valign="top" align="center" rowspan="1" colspan="1">37.8 &#xB1; 8.4</td>
            <td valign="top" align="center" rowspan="1" colspan="1">18.3 &#xB1; 1.6</td>
            <td valign="top" align="center" rowspan="1" colspan="1">2.5:2.1</td>
            <td valign="top" align="center" rowspan="1" colspan="1">ND</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Piperaquine</td>
            <td valign="top" align="center" rowspan="1" colspan="1">80.4</td>
            <td valign="top" align="center" rowspan="1" colspan="1">99.5 &#xB1; 11.7</td>
            <td valign="top" align="center" rowspan="1" colspan="1">56.3 &#xB1; 5.4</td>
            <td valign="top" align="center" rowspan="1" colspan="1">1.4:1.8</td>
            <td valign="top" align="center" rowspan="1" colspan="1">ND</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Dihydroartemisinin</td>
            <td valign="top" align="center" rowspan="1" colspan="1">2.18</td>
            <td valign="top" align="center" rowspan="1" colspan="1">2.46 &#xB1; 0.28</td>
            <td valign="top" align="center" rowspan="1" colspan="1">2.58 &#xB1; 0.13</td>
            <td valign="top" align="center" rowspan="1" colspan="1">0.84:0.95</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;10.5</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Artesunate</td>
            <td valign="top" align="center" rowspan="1" colspan="1">1.86</td>
            <td valign="top" align="center" rowspan="1" colspan="1">1.68 &#xB1; 0.28</td>
            <td valign="top" align="center" rowspan="1" colspan="1">2.27 &#xB1; 1.15</td>
            <td valign="top" align="center" rowspan="1" colspan="1">0.82:0.74</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;10.5</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Atovaquone</td>
            <td valign="top" align="center" rowspan="1" colspan="1">6.5</td>
            <td valign="top" align="center" rowspan="1" colspan="1">5.2 &#xB1; 0.8</td>
            <td valign="top" align="center" rowspan="1" colspan="1">4.2 &#xB1; 0.7</td>
            <td valign="top" align="center" rowspan="1" colspan="1">1.5:1.2</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;490</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Doxycycline</td>
            <td valign="top" align="center" rowspan="1" colspan="1">11,600</td>
            <td valign="top" align="center" rowspan="1" colspan="1">12,600 &#xB1; 1,700</td>
            <td valign="top" align="center" rowspan="1" colspan="1">12,600 &#xB1; 1,000</td>
            <td valign="top" align="center" rowspan="1" colspan="1">0.92:1.0</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&gt;35,000</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <p>*Isolate was obtained from a man who returned to France from French Guiana in June 2010. IC50, 50% inhibitory concentration; ND, not determined.&#x2028;&#x2020;Mean IC50 and standard deviation of 3 different tests on the isolate after culture adaptation.</p>
      </table-wrap-foot>
    </table-wrap>
    <p>The <italic>pfnhe</italic> ms4760 microsatellite showed a profile 3, with 1 repeat of DNNND and 2 repeats of DDDNHNDNHNN. Studies of the <italic>pfnhe-1</italic> polymorphism of worldwide culture-adapted isolates showed that increased numbers of DNNND were associated with decreased quinine susceptibility (<xref rid="R7" ref-type="bibr"><italic>7</italic></xref>). Association of 2 repeats of DNNND and a high quinine IC<sub>50</sub> value was found in a case of clinical failure of quinine in a traveler returning from Senegal (<xref rid="R8" ref-type="bibr"><italic>8</italic></xref>).</p>
    <p>Reinfection was excluded because the patient had stayed in mainland France since his return. The patient reported that he took the quinine as instructed. We report here a clinical and parasitologic failure of quinine treatment associated with high IC<sub>50</sub> but not linked with the ms4760 <italic>pfnhe-1</italic> profile involved with quinine in vitro reduced susceptibility. A hypothesis that may explain our data is that unlike previous studies (<xref rid="R7" ref-type="bibr"><italic>7</italic></xref>), in which the less susceptible strains originated from Asia, this isolate came from South America. The profile associated with quinine resistance for chloroquine resistance and <italic>pfcrt</italic> genotypes could be different in the 3 malaria-endemic continents. There are no data on ms4760 <italic>pfnhe-1</italic> of <italic>P. falciparum</italic> isolates from South America. In another recent study (<xref rid="R9" ref-type="bibr"><italic>9</italic></xref>), a multivariate analysis performed on 83 clinical isolates from Madagascar and 13 African countries did not confirm this association between quinine susceptibility and <italic>pfnhe-1</italic> microsatellite polymorphisms.</p>
    <p>The <italic>pfcrt</italic> gene had a point mutation on codon 76 (76T) and <italic>pfmdr1</italic> on codons 184F, 1034C, 1042D, and 1246Y. These data are in agreement with those from previous studies that showed the mutation 76T in the <italic>pfcrt</italic> gene led to decreased susceptibility to chloroquine, amodiaquine, and quinine. The isolate had only 1 copy of <italic>pfmdr1</italic>. The data on mutations and copy number of <italic>pfmdr1</italic> are consistent with data in Brazil (<xref rid="R10" ref-type="bibr"><italic>10</italic></xref>). Nevertheless, the lack of gene amplification and specific point mutations in <italic>pfmdr1</italic> were not associated with decreased in vitro susceptibility of quinine. <italic>dhfr</italic> and <italic>dhps</italic> genes had a 5-mutation haplotype, 51I C59 108N I164-S436 437G 540E 581G A613, which suggested in vitro resistance to proguanil, pyrimethamine, and sulfadoxine. This case confirms the need to always add doxycycline to quinine for treatment of <italic>P. falciparum</italic> malaria acquired in French Guiana as well as other parts of South America.</p>
  </body>
  <back>
    <fn-group>
      <fn fn-type="citation">
        <p><italic>Suggested citation for this article</italic>: Bertaux L, Kraemer P, Taudon N, Trignol A, Martelloni M, Saidi R, et al. Quinine-resistant malaria in traveler returning from French Guiana, 2010 [letter]. Emerg Infect Dis [serial on the Internet]. 2011 May [<italic>date cited</italic>]. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3201/eid1705.101424">http://dx.doi.org/10.3201/eid1705.101424</ext-link></p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgments</title>
      <p>We thank R&#xE9;my Amalvict, Eric Baret, Nicolas Benoit, Julien Cren, and Dominique Travers for technical support.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1. </label>
        <mixed-citation publication-type="journal"><collab>Soci&#xE9;t&#xE9; de Pathologie Infectieuse de Langue Fran&#xE7;aise</collab>, <collab>Coll&#xE8;ge des Universitaires de Maladies Infectieuses et Tropicales</collab>, <collab>Soci&#xE9;t&#xE9; de M&#xE9;deine des Arm&#xE9;es</collab>, <collab>Soci&#xE9;t&#xE9; Fran&#xE7;aise de Parasitologie</collab>, <collab>Soci&#xE9;t&#xE9; Fran&#xE7;aise de P&#xE9;diatrie</collab>, <collab>Soci&#xE9;t&#xE9; de M&#xE9;deine des Voyages</collab>, <etal/>
<article-title>Management and prevention of imported <italic>Plasmodium falciparum</italic> malaria: recommendations for clinical practice 2007 (revision 2007 of the 1999 consensus conference)</article-title>
<comment>[in French]</comment>
<source>Med Mal Infect</source>. <year>2008</year>;<volume>38</volume>:<fpage>68</fpage>&#x2013;<lpage>117</lpage><pub-id pub-id-type="pmid">18646361</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Demar</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Carme</surname>
<given-names>B</given-names></string-name>. <article-title><italic>Plasmodium falciparum in vivo</italic> resistance to quinine: description of two RIII responses in French Guiana.</article-title>
<source>Am J Trop Med Hyg</source>. <year>2004</year>;<volume>70</volume>:<fpage>125</fpage>&#x2013;<lpage>7</lpage><pub-id pub-id-type="pmid">14993621</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Dedet</surname>
<given-names>JP</given-names></string-name>, <string-name><surname>Germanetto</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Cordoliani</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Bonnevie</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Le Bras</surname>
<given-names>J</given-names></string-name>. <article-title>In vitro activity of various antimalarials (chloroquine, amodiaquine, quinine and mefloquine) against 32 isolates of <italic>Plasmodium falciparum</italic> in French Guiana</article-title>
<comment>[in French]</comment>
<source>Bull Soc Trop Pathol Exot Filiales.</source>
<year>1988</year>;<volume>81</volume>:<fpage>88</fpage>&#x2013;<lpage>93</lpage><pub-id pub-id-type="pmid">3042179</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Legrand</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Volney</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Meynard</surname>
<given-names>JB</given-names></string-name>, <string-name><surname>Mercereau-Puijalon</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Esterre</surname>
<given-names>P</given-names></string-name>. <article-title>In vitro monitoring of <italic>Plasmodium falciparum</italic> drug resistance in French Guiana: a synopsis of continuous assessment from 1994 to 2005.</article-title>
<source>Antimicrob Agents Chemother</source>. <year>2008</year>;<volume>52</volume>:<fpage>288</fpage>&#x2013;<lpage>98</lpage>
<pub-id pub-id-type="doi">10.1128/AAC.00263-07</pub-id><pub-id pub-id-type="pmid">17954693</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Parola</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Pradines</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Simon</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Carlotti</surname>
<given-names>MP</given-names></string-name>, <string-name><surname>Minodier</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Ranjeva</surname>
<given-names>MP</given-names></string-name>, <etal/>
<article-title>Antimalarial drug susceptibility and point mutations associated with <italic>Plasmodium falciparum</italic> drug resistance of 248 isolates imported from Comoros to Marseilles, France in 2004&#x2013;2006.</article-title>
<source>Am J Trop Med Hyg</source>. <year>2007</year>;<volume>77</volume>:<fpage>431</fpage>&#x2013;<lpage>7</lpage><pub-id pub-id-type="pmid">17827355</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Pradines</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Dormoi</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Briolant</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Bogreau</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Rogier</surname>
<given-names>C</given-names></string-name>. <article-title>La r&#xE9;sistance aux antipaludiques.</article-title>
<source>Revue Francophone des Laboratoires.</source>
<year>2010</year>;<volume>422</volume>:<fpage>51</fpage>&#x2013;<lpage>62</lpage>
<pub-id pub-id-type="doi">10.1016/S1773-035X(10)70510-4</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Henry</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Briolant</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Zettor</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Pelleau</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Baragatti</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Baret</surname>
<given-names>E</given-names></string-name>, <etal/>
<article-title><italic>Plasmodium falciparum</italic> Na+/H+ exchanger 1 transporter is involved in reduced susceptibility to quinine.</article-title>
<source>Antimicrob Agents Chemother</source>. <year>2009</year>;<volume>53</volume>:<fpage>1926</fpage>&#x2013;<lpage>30</lpage>
<pub-id pub-id-type="doi">10.1128/AAC.01243-08</pub-id><pub-id pub-id-type="pmid">19273668</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Pradines</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Pistone</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Ezzedine</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Briolant</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Bertaux</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Receveur</surname>
<given-names>MC</given-names></string-name>, <etal/>
<article-title>Quinine-resistant malaria in traveler returning from Senegal, 2007.</article-title>
<source>Emerg Infect Dis</source>. <year>2010</year>;<volume>16</volume>:<fpage>546</fpage>&#x2013;<lpage>8</lpage>
<pub-id pub-id-type="doi">10.3201/eid1603.091669</pub-id><pub-id pub-id-type="pmid">20202443</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Andriantsoanirina</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Menard</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Rabearimanana</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Hubert</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Bouchier</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Tichit</surname>
<given-names>M</given-names></string-name>, <etal/>
<article-title>Association of microsatellite variations of <italic>Plasmodium falciparum</italic> Na+/H+ exchanger (<italic>pfnhe-1</italic>) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa.</article-title>
<source>Am J Trop Med Hyg</source>. <year>2010</year>;<volume>82</volume>:<fpage>782</fpage>&#x2013;<lpage>7</lpage>
<pub-id pub-id-type="doi">10.4269/ajtmh.2010.09-0327</pub-id><pub-id pub-id-type="pmid">20439955</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Zalis</surname>
<given-names>MG</given-names></string-name>, <string-name><surname>Pang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Silveira</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Milhous</surname>
<given-names>WK</given-names></string-name>, <string-name><surname>Wirth</surname>
<given-names>D</given-names></string-name>. <article-title>Characterisation of <italic>Plasmodium falciparum</italic> isolated from the Amazon region of Brazil: evidence for quinine resistance.</article-title>
<source>Am J Trop Med Hyg</source>. <year>1998</year>;<volume>58</volume>:<fpage>630</fpage>&#x2013;<lpage>7</lpage><pub-id pub-id-type="pmid">9598453</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
